Balyasny Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Sell |
13,182
-32,649
| -71% | -$313K | ﹤0.01% | 1871 |
|
|
2025
Q1 | $287K | Buy |
+45,831
| New | +$287K | ﹤0.01% | 1722 |
|
|
2024
Q4 | – | Sell |
-65,659
| Closed | -$1.19M | – | 2276 |
|
|
2024
Q3 | $1.19M | Buy |
65,659
+50,653
| +338% | +$916K | ﹤0.01% | 1274 |
|
|
2024
Q2 | $155K | Buy |
+15,006
| New | +$155K | ﹤0.01% | 1739 |
|
|
2022
Q4 | – | Sell |
-18,532
| Closed | -$205K | – | 2645 |
|
|
2022
Q3 | $205K | Buy |
+18,532
| New | +$205K | ﹤0.01% | 1824 |
|